X4 Pharmaceuticals Inc. (XFOR)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
3. 82
-0.01
-0.2611%
$
415.95M Market Cap
- P/E Ratio
- Div Yield
461,900 Volume
-0.63 Eps
$ 3.83
Previous Close 
Want to track XFOR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
X4 Pharmaceuticals Inc. (XFOR) Statistics
Valuation metrics
Market Cap 415.95M
Enterprise value 220.65M
Trailing P/E (ttm) -0.84
Forward P/E -4.32
PEG ratio 0
Price/Sales (ttm) 39.97
Price/Book (mrq) 2.86
Enterprise Value/Revenue 24.48
Enterprise Value/EBITDA -2.46
Overview
Shares outstanding 90.91M
Float 64.55M
Shares short 3.12M
% Held by insiders 0.01%
% Held by institutions 0.9%
Average volume (10 days) 458.39K
Average volume (90 days) 684.11K
Price summary
52-Week low 1.35
52-Week high 4.83
Beta 0.33
50-Day moving average 4.04
200-Day moving average 3.91
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:30
Last split Date 28 Apr 2025
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -11.06%
Operating margin -10.84%
Operational effectiveness
Return on assets -0.37%
Return on equity -0.95%
Income Statement
Revenue (ttm) 35.11M
Revenue per share (ttm) 0.07
Quarterly revenue growth (yoy) 0.79%
Gross profit (ttm) 29.36M
EBITDA -78.61M
Net income to common (ttm) -79.2M
Diluted EPS (ttm) -0.79
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 253M
Total cash per share (mrq) 1.85
Total debt (mrq) 77.28M
Total Debt/Equity (mrq) 0.46
Current ratio (mrq) 10.18%
Book value per share (mrq) 1.33
Cash Flow
Cash flow statement -85.62M
Levered free cash flow (LFCF) -57.36M
